These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 22464098

  • 1. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.
    Goel D, Bhatnagar R.
    Mol Immunol; 2012 Jun; 51(2):159-68. PubMed ID: 22464098
    [Abstract] [Full Text] [Related]

  • 2. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D, Rajendran V, Ghosh PC, Bhatnagar R.
    Vaccine; 2013 Feb 06; 31(8):1231-7. PubMed ID: 23273966
    [Abstract] [Full Text] [Related]

  • 3. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
    Paul S, Peddayelachagiri BV, Nagaraj S, Konduru B, Batra HV.
    Appl Microbiol Biotechnol; 2018 Oct 06; 102(20):8895-8907. PubMed ID: 30136204
    [Abstract] [Full Text] [Related]

  • 4. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
    Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.
    Infect Immun; 2009 Jan 06; 77(1):436-45. PubMed ID: 18981242
    [Abstract] [Full Text] [Related]

  • 5. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
    Paul S, Peddayelachagiri BV, Nagaraj S, Kingston JJ, Batra HV.
    Mol Immunol; 2018 Jul 06; 99():9-18. PubMed ID: 29649688
    [Abstract] [Full Text] [Related]

  • 6. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
    Delpino MV, Estein SM, Fossati CA, Baldi PC, Cassataro J.
    Vaccine; 2007 Sep 17; 25(37-38):6721-9. PubMed ID: 17686554
    [Abstract] [Full Text] [Related]

  • 7. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J, Walravens K, Letesson JJ.
    Infect Immun; 2001 Aug 17; 69(8):4816-22. PubMed ID: 11447155
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J, Estein SM, Pasquevich KA, Velikovsky CA, de la Barrera S, Bowden R, Fossati CA, Giambartolomei GH.
    Infect Immun; 2005 Dec 17; 73(12):8079-88. PubMed ID: 16299302
    [Abstract] [Full Text] [Related]

  • 9. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
    Solanki KS, Varshney R, Qureshi S, Thomas P, Singh R, Agrawal A, Chaudhuri P.
    Int Immunopharmacol; 2021 Jan 17; 90():107148. PubMed ID: 33189614
    [Abstract] [Full Text] [Related]

  • 10. The protein moiety of Brucella abortus outer membrane protein 16 is a new bacterial pathogen-associated molecular pattern that activates dendritic cells in vivo, induces a Th1 immune response, and is a promising self-adjuvanting vaccine against systemic and oral acquired brucellosis.
    Pasquevich KA, García Samartino C, Coria LM, Estein SM, Zwerdling A, Ibañez AE, Barrionuevo P, Oliveira FS, Carvalho NB, Borkowski J, Oliveira SC, Warzecha H, Giambartolomei GH, Cassataro J.
    J Immunol; 2010 May 01; 184(9):5200-12. PubMed ID: 20351187
    [Abstract] [Full Text] [Related]

  • 11. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M, Rafati S, Siadat SD, Nejati-Moheimani M, Shahcheraghi F, Arsang A, Bouzari S.
    Mol Immunol; 2015 Aug 01; 66(2):384-91. PubMed ID: 25968974
    [Abstract] [Full Text] [Related]

  • 12. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
    Gupta S, Singh D, Gupta M, Bhatnagar R.
    Pathog Dis; 2019 Nov 01; 77(8):. PubMed ID: 31971564
    [Abstract] [Full Text] [Related]

  • 13. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT, Arayan LT, Huy TXN, Reyes AWB, Min W, Lee HJ, Park SJ, Chang HH, Kim S.
    Vaccine; 2018 May 17; 36(21):3027-3033. PubMed ID: 29678458
    [Abstract] [Full Text] [Related]

  • 14. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A, Jeddi-Tehrani M, Mautner J, Salari MH, Zarnani AH.
    Vaccine; 2014 Nov 20; 32(49):6659-66. PubMed ID: 25240754
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice.
    Hop HT, Simborio HL, Reyes AW, Arayan LT, Min W, Lee HJ, Kim DH, Chang HH, Kim S.
    FEMS Microbiol Lett; 2015 Feb 20; 362(4):. PubMed ID: 25724777
    [Abstract] [Full Text] [Related]

  • 16. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
    Mallick AI, Singha H, Chaudhuri P, Nadeem A, Khan SA, Dar KA, Owais M.
    Vaccine; 2007 May 04; 25(18):3692-704. PubMed ID: 17296251
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G, Singh AK, Balakrishna K, Murali HS, Batra HV.
    Mol Immunol; 2016 Mar 04; 71():34-41. PubMed ID: 26826463
    [Abstract] [Full Text] [Related]

  • 18. An RNA vaccine based on recombinant Semliki Forest virus particles expressing the Cu,Zn superoxide dismutase protein of Brucella abortus induces protective immunity in BALB/c mice.
    Oñate AA, Donoso G, Moraga-Cid G, Folch H, Céspedes S, Andrews E.
    Infect Immun; 2005 Jun 04; 73(6):3294-300. PubMed ID: 15908354
    [Abstract] [Full Text] [Related]

  • 19. Elicitation of Th1/Th2 related responses in mice by chitosan nanoparticles loaded with Brucella abortus malate dehydrogenase, outer membrane proteins 10 and 19.
    Shim S, Soh SH, Im YB, Park HE, Cho CS, Kim S, Yoo HS.
    Int J Med Microbiol; 2020 Jan 04; 310(1):151362. PubMed ID: 31676233
    [Abstract] [Full Text] [Related]

  • 20. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
    Vrushabhendrappa, Singh AK, Balakrishna K, Sripathy MH, Batra HV.
    Vaccine; 2014 Sep 29; 32(43):5600-6. PubMed ID: 25131740
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.